Epigenetic Mechanisms in Diabetic Kidney Disease

Current Diabetes Reports
Merlin C Thomas

Abstract

Progressive kidney disease is a common companion to both type 1 and type 2 diabetes. However, the majority of people with diabetes do not develop diabetic kidney disease. This may in part be explained by good control of glucose, blood pressure, obesity and other risk factors for kidney disease. It may also be partly due to their genetic makeup or ethnicity. However, the vast majority of the variability in incident nephropathy remains unaccounted for by conventional risk factors or genetics. Epigenetics has recently emerged as an increasingly powerful paradigm to understand and potentially explain complex non-Mendelian conditions-including diabetic kidney disease. Persistent epigenetic changes can be acquired during development or as adaptations to environmental exposure, including metabolic fluctuations associated with diabetes. These epigenetic modifications-including DNA methylation, histone modifications, non-coding RNAs and other changes in chromatin structure and function-individually and co-operatively act to register, store, retain and recall past experiences in a way to shape the transcription of specific genes and, therefore, cellular functions. This review will explore the emerging evidence for the role of epigenetic ...Continue Reading

References

Oct 23, 2003·JAMA : the Journal of the American Medical Association·UNKNOWN Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Resea
Mar 17, 2007·Diabetes·Sudha K IyengarUNKNOWN Family Investigation of Nephropathy and Diabetes Research Group
Jun 7, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Robert A WaterlandKajal G Tahiliani
Mar 14, 2008·The New England Journal of Medicine·Manel Esteller
Jul 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Patrick S MitchellMuneesh Tewari
Sep 24, 2008·The Journal of Experimental Medicine·Assam El-OstaMichael Brownlee
Oct 10, 2008·The New England Journal of Medicine·John Chalmers, Mark E Cooper
Oct 29, 2008·Proceedings of the National Academy of Sciences of the United States of America·Bastiaan T HeijmansL H Lumey
Aug 7, 2010·BMC Medical Genomics·Christopher G BellDavid A Savage
Dec 15, 2010·Circulation Research·Mark E Cooper, Assam El-Osta
Dec 15, 2010·Epigenetics : Official Journal of the DNA Methylation Society·Carmen SapienzaMichael Madaio
Jan 25, 2011·Reproductive Toxicology·Frederica Perera, Julie Herbstman
Mar 3, 2011·Epigenetics : Official Journal of the DNA Methylation Society·Guillaume RivièreFelix J Frey
Jun 29, 2011·Diabetes·Phillip KantharidisHui Yao Lan
Nov 19, 2011·Journal of the American Society of Nephrology : JASN·Bo WangPhillip Kantharidis
Jan 21, 2012·The Review of Diabetic Studies : RDS·Cristina Bianchi, Stefano Del Prato
Feb 9, 2012·Current Opinion in Nephrology and Hypertension·Merlin C ThomasKarl Tryggvason
Feb 18, 2012·Nature·Mitchell Guttman, John L Rinn
Mar 10, 2012·Circulation Research·Jun OkabeAssam El-Osta
Jul 10, 2012·Molecular Aspects of Medicine·F I MilagroJ A Martínez
Jul 25, 2013·Free Radical Biology & Medicine·Xinghua ChengRichard C M Siow
Oct 4, 2013·Kidney International·Marpadga A ReddyRama Natarajan
Nov 20, 2013·Current Opinion in Nephrology and Hypertension·Aaron McClellandPhillip Kantharidis
Apr 12, 2014·Frontiers in Genetics·Jan-Wilhelm Kornfeld, Jens C Brüning
May 2, 2014·Advances in Chronic Kidney Disease·Merlin C Thomas
Jul 7, 2014·Endocrine·Yuriy SlyvkaFelicia V Nowak
Aug 1, 2014·American Journal of Physiology. Renal Physiology·L J SmythA J McKnight
Sep 23, 2014·The New England Journal of Medicine·Sophia ZoungasUNKNOWN ADVANCE-ON Collaborative Group
Oct 31, 2014·Proceedings. Biological Sciences·Hendrik EggertMaike F Diddens-de Buhr
Nov 18, 2014·Current Opinion in Nephrology and Hypertension·Vicki Thallas-BonkeMark E Cooper
Dec 8, 2014·Diabetologia·Marpadga A ReddyRama Natarajan
Feb 6, 2015·Journal of the American Society of Nephrology : JASN·Takeshi MarumoToshiro Fujita
Apr 15, 2015·The Journal of Clinical Endocrinology and Metabolism·M Luiza CaramoriMichael Mauer
Jan 1, 2015·Nature Reviews. Disease Primers·Merlin C ThomasMark E Cooper

❮ Previous
Next ❯

Citations

Apr 25, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Benjamin P LarkinSonia Saad
Dec 16, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Sophie LimouAfshin Parsa
Nov 10, 2017·American Journal of Physiology. Endocrinology and Metabolism·Anu Alice ThomasSubrata Chakrabarti
Jul 2, 2017·Clinical Science·Anna WitaspLouise Nordfors
Nov 13, 2017·Diabetologia·Samuel T KeatingAssam El-Osta
Sep 1, 2018·Acta Diabetologica·Taís S AssmannDaisy Crispim
Jul 12, 2017·Journal of Diabetes Research·Jing SunLining Miao
Jun 25, 2019·Frontiers in Genetics·Harvest F Gu
Apr 13, 2017·Journal of Diabetes Research·Zeyuan LuFeng Wang
Mar 21, 2019·Journal of Diabetes Research·Yan LiHuakui Zhan
Dec 15, 2020·Epigenetics : Official Journal of the DNA Methylation Society·Fenglin WangSamir S El-Dahr
Jul 30, 2020·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·Xun FangHongyan Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

Expert Review of Endocrinology & Metabolism
Louisa M Villeneuve, Rama Natarajan
Diabetes Research and Clinical Practice
Gurinder Bir SinghMadhu Khullar
Journal of the Neurological Sciences
Ya FengYun-Cheng Wu
© 2022 Meta ULC. All rights reserved